A vaccine strategy with multiple prostatic acid phosphatase-fused cytokines for prostate cancer treatment

Immunotherapy is one of the attractive treatment strategies for advanced prostate cancer. The US Food and Drug Administration (FDA) previously approved the therapeutic vaccine, sipuleucel-T, which is composed of autologous antigen-presenting cells cultured with a fusion protein [prostatic acid phosp...

Descripción completa

Detalles Bibliográficos
Autores principales: FUJIO, KEI, WATANABE, MASAMI, UEKI, HIDEO, LI, SHUN-AI, KINOSHITA, RIE, OCHIAI, KAZUHIKO, FUTAMI, JUNICHIRO, WATANABE, TOYOHIKO, NASU, YASUTOMO, KUMON, HIROMI
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4358080/
https://www.ncbi.nlm.nih.gov/pubmed/25632844
http://dx.doi.org/10.3892/or.2015.3770

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4358080/
https://www.ncbi.nlm.nih.gov/pubmed/25632844
http://dx.doi.org/10.3892/or.2015.3770

Ejemplares similares